跳至主要内容
临床试验/NCT05833321
NCT05833321招募中不适用

Prospective Monocentric Study of the Detection of Sarcopenia in Clinical Practice in Patients With Ovarian or Endometrial Cancer Requiring Systemic Oncological Treatment

Centre Hospitalier Metropole Savoie2 个研究点 分布在 1 个国家目标入组 75 人开始时间: 2022年11月20日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
75
试验地点
2
主要终点
Proposal of a composite score for the detection of sarcopenia usable in clinical routine

研究概览

简要总结

Prospective monocentric study, non-randomized of the detection of sarcopenia in clinical practice in patients with ovarian or endometrial cancer requiring systemic oncological treatment.

main question : Identify the criteria correlated with the presence of sarcopenia (defined by the measurement of the IMS by the CT-X method in L3) among the impedancemetry and the HAS malnutrition criteria.

Data collection will be done at 6 months, 12 months after the date of inclusion.

详细描述

Primary objective:Identify the criteria correlated to the presence of sarcopenia (defined by the measurement of the IMS by the CT-X method in L3) among the impedancemetry and the HAS malnutrition criteria

Main judgment criteria : Comparison between the groups of patients with sarcopenia (Morphometric measurement of the musculoskeletal surface index <39cm²/m² in L3 cross section) and without sarcopenia of the different evaluation criteria:

  • Impedancemetry values:: muscle mass index in kg/m2 (IMS), fat-free mass in kg/m2 and metabolic activity index (phase angle)
  • Percentage of weight loss
  • BMI < 18.5 kg/m2
  • Quantified reduction in muscle mass and/or function for patients < 70 years old
  • Quantified reduction in muscle mass and function for patients > 70 years old
  • Physical tests: walking speed and "hand grip" dynamometer secondary objectives:- Proposal of a composite score for the detection of sarcopenia usable in clinical routine
  • Evaluation of nutritional intake
  • Evaluation of the severity of undernutrition
  • Verification of a correlation between the sarcopenia indices of ovarian and endometrial cancer
  • Evaluate tolerance profiles to systemic treatments with regard to sarcopenia figures
  • Assess the relationship between PFS, OS and sarcopenia index in cancer diagnosis secondary judgment criteria :
  • Statistical analysis of sarcopenia and undernutrition data
  • Quantification of ingestates (SEFI scale) +/- intake of oral nutritional supplement
  • Serological tests: NFS, CRP and Albuminemia
  • Comparison of sarcopenia index figures between ovarian and endometrial cancer
  • Collection of the grades of toxicities and adverse events to systemic treatments in parallel with the measurement of sarcopenia.
  • Correlation between progression-free survival, death and sarcopenia index at cancer diagnosis

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Diagnostic
盲法
None

盲法说明

Inclusion criteria:

  • Patients at least 18 years old
  • Patient presenting with a diagnosis of cancer of ovarian origin with an indication for chemotherapy
  • Patient with a diagnosis of endometrial cancer with an indication for chemotherapy
  • Patient with no diagnosis of other types of cancer in the previous five years
  • Collection of consent
  • Patient affiliated to a Social Security scheme Non-inclusion criteria
  • Patient with cancer of ovarian origin not requiring chemotherapy treatment
  • Patient with endometrial cancer not requiring chemotherapy treatment
  • Discovery of an intercurrent cancer other than skin or cervix cancers.
  • Patient wearing a Pace maker

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • Patients at least 18 years old
  • Patient presenting with a diagnosis of cancer of ovarian origin with an indication for chemotherapy
  • Patient with a diagnosis of endometrial cancer with an indication for chemotherapy
  • Patient with no diagnosis of other types of cancer in the previous five years
  • Collection of consent
  • Patient affiliated to a Social Security scheme

排除标准

  • Patient with cancer of ovarian origin not requiring chemotherapy treatment
  • Patient with endometrial cancer not requiring chemotherapy treatment
  • Discovery of an intercurrent cancer other than skin or cervix cancers.
  • Patient wearing a Pace maker

结局指标

主要结局

Proposal of a composite score for the detection of sarcopenia usable in clinical routine

时间窗: 36 month

Statistical analysis of sarcopenia and undernutrition data

clinical screening for sarcopenia

时间窗: 36 month

Identify the criteria correlated with the presence of sarcopenia (defined by the measurement of the IMS by the CT-X method in L3) among the impedancemetry and the HAS malnutrition criteria.

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验

Prospective Study of Detection of Sarcopenia in... | 临床试验